Immunotherapy
Latest immunotherapy news
1 article
Companies
Scancell increases its capital raise to £13 million following strong demand
Scancell raises its UK placement to £13 million due to strong demand. It will issue 144.4 million new shares and merge with a SPAC to list on Nasdaq.